Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy

Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide. Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such as radiofrequency ablation (RFA) or transarterial chemoembolization (TACE). However, recurrences following LRTs are common, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ji-Won, Yoon, Seung-Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471821/
https://www.ncbi.nlm.nih.gov/pubmed/34575463
http://dx.doi.org/10.3390/pharmaceutics13091387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471821/
https://www.ncbi.nlm.nih.gov/pubmed/34575463
http://dx.doi.org/10.3390/pharmaceutics13091387

Ejemplares similares